We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+11.87%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.69%
AUM
$1.14B
AUM Growth
+$62.6M
Cap. Flow
-$68.5M
Cap. Flow %
-6%
Top 10 Hldgs %
20.56%
Holding
206
New
27
Increased
44
Reduced
47
Closed
29

Top Buys

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$19M
2
AXSM icon
Axsome Therapeutics
AXSM
+$12M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$11.2M
4
CHX
ChampionX
CHX
+$11M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$10.5M

Top Sells

Rank Stock Value
1
SWTX
SpringWorks Therapeutics
SWTX
+$15.9M
2
UTHR icon
United Therapeutics
UTHR
+$14.3M
3
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$13.4M
4
STAA icon
STAAR Surgical
STAA
+$11.7M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$11.6M

Sector Composition

Rank Sector Weight
1 Healthcare 44.14%
2 Technology 14.06%
3 Industrials 9.62%
4 Energy 8.22%
5 Financials 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RXDX
1
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$31.2M 2.73%
283,246
-205,989
-42% -$13.4M
CYTK icon
2
Cytokinetics
CYTK
$10.4B
$25.3M 2.21%
551,128
+78,289
+17% +$3.37M
ARGX icon
3
argenx
ARGX
$52B
$25.1M 2.2%
66,145
-104
-0.2% -$38.9K
ESTA icon
4
Establishment Labs
ESTA
$2.73B
$24.1M 2.11%
367,174
-456
-0.1% -$27.6K
WSC icon
5
WillScot Mobile Mini Holdings
WSC
$4.66B
$23M 2.02%
509,772
-70,831
-12% -$3.18M
EXE
6
Expand Energy Corp
EXE
$21.9B
$22.1M 1.94%
234,639
-41,502
-15% -$4.11M
ITCI
7
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$21.9M 1.92%
413,507
+22,829
+6% +$1.14M
KRYS icon
8
Krystal Biotech
KRYS
$9.21B
$21.2M 1.85%
267,089
+45,063
+20% +$3.34M
INSP icon
9
Inspire Medical Systems
INSP
$1.5B
$20.6M 1.8%
81,735
+13,564
+20% +$2.89M
ASND icon
10
Ascendis Pharma A/S
ASND
$16B
$20.3M 1.78%
165,937
+28,383
+21% +$3.3M
LEGN icon
11
Legend Biotech
LEGN
$3.68B
$19.9M 1.75%
399,115
-371
-0.1% -$18K
KRTX
12
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$19.1M 1.67%
97,128
+19,874
+26% +$4.26M
XOM icon
13
ExxonMobil
XOM
$643B
$18M 1.58%
163,000
– –
TMDX icon
14
Transmedics
TMDX
$2.82B
$17.9M 1.57%
289,704
+12,079
+4% +$642K
SWAV
15
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$17.4M 1.52%
84,507
-11,269
-12% -$2.85M
DAWN
16
DELISTED
Day One Biopharmaceuticals
DAWN
$16.9M 1.48%
786,554
+29,147
+4% +$598K
KDNY
17
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$16.8M 1.48%
642,720
+75,305
+13% +$1.67M
NARI
18
DELISTED
Inari Medical, Inc. Common Stock
NARI
$16.5M 1.45%
260,123
+7,747
+3% +$562K
MPWR icon
19
Monolithic Power Systems
MPWR
$66B
$16.1M 1.41%
45,609
+6,774
+17% +$2.43M
LNTH icon
20
Lantheus
LNTH
$6.59B
$15.7M 1.38%
+308,295
New +$19M
TFII icon
21
TFI International
TFII
$11.1B
$15.5M 1.36%
154,906
-12,079
-7% -$1.21M
AXSM icon
22
Axsome Therapeutics
AXSM
$10.9B
$15.4M 1.35%
+200,254
New +$12M
CACI icon
23
CACI
CACI
$11.3B
$15.1M 1.32%
50,277
+742
+1% +$216K
RGEN icon
24
Repligen
RGEN
$8.3B
$14.8M 1.3%
87,487
-235
-0.3% -$42.6K
BJ icon
25
BJs Wholesale Club
BJ
$12.4B
$14.6M 1.28%
221,303
-1,984
-0.9% -$144K
1
2 3 4 5

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Nicholas Investment Partners held 206 positions worth $1.14B, up 5.8% from $1.08B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Nicholas Investment Partners withdrew a net $68.5M in Q4 2022, closing 29 positions and reducing 47 holdings. Its most notable exit was SpringWorks Therapeutics, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 44% a quarter earlier, followed by Technology and Industrials.

Against the trend, Nicholas Investment Partners opened a new position in Lantheus worth $15.7M.

  • Nicholas Investment Partners's largest Q4 2022 buy was Lantheus: 308,295 shares worth $15.7M.
  • Nicholas Investment Partners added most to Wintrust Financial in Q4 2022, an estimated $5.83M increase.
  • Nicholas Investment Partners's biggest Q4 2022 reduction was Prometheus Biosciences, Inc. Common Stock, cutting an estimated $13.4M.
  • Nicholas Investment Partners fully exited SpringWorks Therapeutics in Q4 2022, selling an estimated $15.9M.
  • Nicholas Investment Partners's ten largest holdings make up 21% of its $1.14B portfolio in Q4 2022.
  • Nicholas Investment Partners opened 27 new positions and closed 29 in Q4 2022.
  • Nicholas Investment Partners's portfolio value rose 5.8% quarter-over-quarter to $1.14B.

Based on Nicholas Investment Partners's 13F filing for Q4 2022, filed 10 Feb 2023.